Stock info AC Immune SA | Filter  Basic-Info

Stock: AC Immune SA (US broad)

Last Price 2.31 Max Price 4.20
Min Price 1.48 1 Year return 0.00
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USA

Sector Review AC Immune SA

Loading...
Year Turnover Total sector Market share
2019 102 135,969 0.08 %
2020 14 152,939 0.01 %
2021 0 227,396 0.00 %
2022 3 260,129 0.00 %
2023 15 214,794 0.01 %

Advice AC Immune SA

No Records Found



News AC Immune SA

No Records Found

Annual reports AC Immune SA

No Records Found

Profile AC Immune SA

No Records Found

Results AC Immune SA

Results
2015
2016
2017
2018
2019
2020
Revenue
35
21
17
6
102
14
Costs
17
27
39
51
61
71
Profit
18
-6
-22
-45
41
-57
Margin of profit
51.43
-28.57
-129.41
-750.00
40.20
-407.14
ROI
27.69
-4.51
-22.22
-28.66
16.33
-28.64

Balance AC Immune SA

Balance
2015
2016
2017
2018
2019
2020
Equity
65
133
99
157
251
199
Debt
8
12
13
17
24
21
Total assets
73
145
112
174
275
220
Solvency
89.04
91.72
88.39
90.23
91.27
90.45
Cash
70
142
106
165
266
208
Cashflow
40
-5
-18
-39
50
-55
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
5.00
-0.42
-1.38
-2.29
2.08
-2.62

Details AC Immune SA

Details
2016
2017
2018
2019
2020
Price
0.0
12.98
12.80
9.45
8.52
Eps
0.0
0.0
0.0
0.0
Price/earnings-ratio
0.0
0.0
0.0
0.0
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
2.34
1.73
2.32
3.49
2.77
Market to book
0.0
0.13
0.18
0.37
1.20
Cashflow per stock
-0.09
-0.31
-0.58
0.70
-0.76
Stocks
57
57
68
72
72
Market Cap
0.00
744.47
864.80
679.07
166.17

Dividend AC Immune SA

Price info AC Immune SA

Date
Price
23 Jul 2025
2.31
18 Jul 2025
2.07
17 Jul 2025
2.07
16 Jul 2025
2.06
15 Jul 2025
2.05
14 Jul 2025
2.08
11 Jul 2025
2.04
10 Jul 2025
2.11
09 Jul 2025
2.08
08 Jul 2025
2.07
07 Jul 2025
1.99
03 Jul 2025
2.07
02 Jul 2025
2.02
01 Jul 2025
1.98
30 Jun 2025
2.03
27 Jun 2025
2.01
26 Jun 2025
2.09
25 Jun 2025
2.07
24 Jun 2025
2.10
23 Jun 2025
1.83
20 Jun 2025
1.88
18 Jun 2025
1.98
17 Jun 2025
1.92
16 Jun 2025
1.94
13 Jun 2025
1.95
12 Jun 2025
2.07
11 Jun 2025
2.12
10 Jun 2025
2.20
09 Jun 2025
2.10
06 Jun 2025
2.04
Overig aandelennieuws
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
AC Immune Announces Pricing of Underwritten Offering of Common Shares
Analist
Returns European stocks
Crypto currencies information
About us Network Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2025 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo